Evidence map›Paper›PMID 39381616›Full record

ArticleRisk management and healthcare policy2024

Trend Analysis of Lung Cancer Incidence and Mortality in Xiamen (2011-2020).

Jianni Cong, Jiahuang Chi, Junli Zeng, Yilan Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Risk management and healthcare policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jianni Cong *School of Health Management, Binzhou Medical University, Shandong, People's Republic of China.ORCID 0000-0002-7297-650X
Jiahuang Chi *Department of Chronic and Non-Communicable Diseases Control and Prevention, Xiamen Center for Disease Control and Prevention, Xiamen, People's Republic of China.
Junli ZengDepartment of Respiratory Center, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Yilan LinDepartment of Chronic and Non-Communicable Diseases Control and Prevention, Xiamen Center for Disease Control and Prevention, Xiamen, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To analyze the trends of lung cancer incidence and mortality in Xiamen from 2011 to 2020 and provide some clues for the lung cancer prevention and control. Methods: The data was obtained from the Xiamen City Cancer Register in Fujian Province, China. The data was updated on Sep 30, 2023. The codes of C33-C34 were used to identify the lung cancer. The newly diagnosed lung cancer patients during the period of 2011-2020 in Xiamen City were included in the evaluation of incidence and mortality and Cox analysis. Results: A total of 11408 lung cancer patients were enrolled. The crude incidence rate was 52.78 per 100000 and the age-standardized incidence rate (ASIWR) was 40.67 per 100000 from 2011 to 2020. Both the crude incidence rate of lung cancer (AAPC =5.92, Conclusion: Lung cancer incidence in Xiamen increased, while mortality decreased with improved survival. Developing more perfect need to consider the differences in the social environment and other factors.

Indexed as

incidencelung cancermortalitysurvival analyzetrend

Identifiers

PMID39381616
PMCPMC11460350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.